Enhancing Endocrine Therapy Combination Strategies for the Treatment of Postmenopausal HR+/HER2– Advanced Breast Cancer

Breast cancer (BC) is the most common malignancy in women worldwide, with approximately two‐thirds having hormone receptor‐positive (HR+) tumors. New endocrine therapy (ET) strategies include combining ET agents as well as adding inhibitors targeting growth factors, angiogenesis, the mechanistic tar...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncologist
Egile Nagusiak: Pritchard, Kathleen I., Chia, Stephen K., Simmons, Christine, McLeod, Deanna, Paterson, Alexander, Provencher, Louise, Rayson, Daniel
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Wiley-Blackwell 2016
Gaiak:
Breast Cancer
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5313264/
https://ncbi.nlm.nih.gov/pubmed/27864574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0185
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak